ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

Immune Therapy Possible For Metastatic Breast Cancer

September 24, 2004

Dana-Farber Opens Imaging Center

May 8, 2009